PL: the cashflow

MyFinsight

For the quarter ending 2025-10-31.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-10-31	2025-07-31	2025-04-30	2024-10-31
Revenue	-	139,651	66,265	-
Cost of revenue	-	39,741	19,151	-
Research and development expense	-	35,751	17,376	-
Sales and marketing	-	29,719	14,287	-
General and administrative	-	26,834	14,252	-
Depreciation and amortization	-	21,704	11,082	-
Stock-based compensation	-	25,998	12,542	-
Restructuring costs	-	20	20	-
Certain litigation expenses	-	615	326	-
Other segment items	-	-5,511	-10,143	-
Consolidated net loss	-94,405	-35,220	-12,628	-88,042
Depreciation and amortization	31,612	21,704	11,082	36,365
Stock-based compensation, net of capitalized cost of 1,892 and 1,793, respectively	39,471	25,998	12,542	36,467
Change in fair value of warrant liabilities	38,765	-4,708	-10,387	-1,126
Change in fair value of contingent consideration	2,071	676	-41	3,161
Other	1,772	1,538	1,229	-932
Accounts receivable	-7,344	-2,363	21,185	-5,487
Prepaid expenses and other assets	-1,052	-272	-1,254	-8,499
Accounts payable, accrued and other liabilities	-10,320	-4,342	-8,915	-7,731
Deferred revenue	96,623	75,813	42,072	71
Deferred hosting costs	-272	1,026	2,323	-298
Net cash provided by (used in) operating activities	113,713	85,120	17,346	-8,079
Purchases of property and equipment	55,114	28,410	8,119	32,694
Capitalized internal-use software	3,398	2,420	1,225	4,145
Maturities of available-for-sale securities	45,017	27,131	11,123	57,046
Sales of available-for-sale securities	33,079	9,254	582	162,341
Purchases of available-for-sale securities	207,138	22,361	0	105,582
Business acquisition, net of cash acquired	0	0	0	1,068
Purchases of licensed imagery intangible assets	1,153	892	621	4,558
Other	0	0	0	300
Net cash provided by (used in) investing activities	-188,707	-17,698	1,740	71,040
Proceeds from the exercise of common stock options	19,932	8,451	2,962	332
Payments for withholding taxes related to the net share settlement of equity awards	28,319	12,436	5,264	7,328
Proceeds from employee stock purchase program	1,851	1,163	346	1,083
Payments of contingent consideration for business acquisitions	4,047	4,820	4,820	8,783
Payment of indemnification holdback for business acquisition	5,000	-	-	-
Proceeds from issuance of convertible notes, net of discount	448,759	-	-	-
Payment of debt issuance costs	2,929	-	-	-
Proceeds from the exercise of warrants	64	-	-	-
Purchase of capped call transactions	39,560	-	-	-
Other	-2,659	-2,521	-2,383	-606
Net cash provided by (used in) financing activities	388,092	-10,163	-9,159	-15,302
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents	6,530	5,677	5,683	74
Net increase in cash and cash equivalents, and restricted cash and cash equivalents	319,628	62,936	15,610	47,733
Cash and cash equivalents at beginning of period	129,994	129,994	129,994	102,198
Cash and cash equivalents at end of period	449,622	192,930	145,604	149,931

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

PL: the cashflow